Category: Press Releases
Cholangiocarcinoma Foundation celebrates FDA’s Acceptance Of New Drug Application For Infigratinib For The Treatment Of Cholangiocarcinoma
On behalf of patients and families impacted by cholangiocarcinoma, the Cholangiocarcinoma Foundation (CCF) celebrates the December 1, 2020 FDA acceptance…
Stacie Lindsey to Receive Luminary Award for Advances in GI Cancers
Stacie C. Lindsey, Chief Executive Officer & Founder of the Cholangiocarcinoma Foundation is one of five leading individuals who will…
CCF wants you to join it’s first ever Turkey Trot
Join the Cholangiocarcinoma Foundation's first Virtual Turkey Trot Run/Bike/Walk! TeamCCF and the Cholangiocarcinoma Foundation are hosting their 1st Annual Virtual…
2021 Cholangiocarcinoma Annual Conference to be held March 31 Through April 2, 2021
Drs. Bridgewater and Meric-Bernstram to Chair The 8th Annual Cholangiocarcinoma Foundation Conference will be held virtually March 31st- April 2nd,…
Cholangiocarcinoma Foundation Consortium Moves to Clarify and Promote Consistent Use of Common Terms for Biomarker and Germline Genetic Testing
Improved Communication Is Vital Between Patients and Providers About Testing Needs WASHINGTON, DC (July 7, 2020) — A LUNGevity Foundation-led…
CCF Wants You to Move for a Cure
Read the full article by clicking here.
The Cholangiocarcinoma Foundation's Annual Conference Will Now Be a Virtual Event
Read the full article by clicking here.
February 12th is World Cholangiocarcinoma Day
Read the full article by clicking here.
CCF Comes to Chicago
Read the full article by clicking here.
AMMF, Cholangiocarcinoma Foundation, TargetCancer Foundation, and The Bili Project, Award Unique Collaborative Grant
Read the full article by clicking here.